|
Device Problems
Activation, Positioning or Separation Problem (2906); Device Dislodged or Dislocated (2923)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Type
malfunction
|
Manufacturer Narrative
|
The physician in this case consented to participate in the survey but did not consent to be contacted regarding the information provided and wished to remain anonymous, therefore information for facility and city cannot be provided.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the endeavor resolute rx coronary drug-eluting stent.Survey results from an interventional cardiologist in practice 25 years.In the past 12 months, the physician has used the endeavor resolute stent 100 times.20 of the smallest (2.25 x 8 mm), 50 intermediate (2.25 x 12 mm to 4.00 x 34 mm) and 30 of the largest sizes (4.00 x 38 mm) of these stents were used.It was noted that the device was used in other non-coronary procedures including 20 devices being used to treat carotid artery-ptas.The following device complaints were encountered in procedure when using the endeavor resolute product over the last 12 months: deployment difficulties were encountered in two cases with no impact on the procedure.Stent dislocation was reported in one case and resulted in no impact on the procedure.It was reported that in 10 cases the device did not perform as expected in terms of reaching the target lesion due to coronary morphology in the blood vessel.It was reported that in 10 cases the device did not perform as expected in terms of dilation of the target lesion.It was stated that this was due to type of lesion in the target vessel.
|
|
Search Alerts/Recalls
|
|
|